mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.4 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.4 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |